Cargando…
Three cases of severe adolescent asthma treated with mepolizumab: lung function trajectories
Real-world experience with mepolizumab for pediatric asthma is still limited. We report 3 patients who were treated with mepolizumab for severe adolescent asthma. Two patients, a 12-year-old boy and a 14-year-old girl, responded well to mepolizumab and showed apparent improvement in lung function fr...
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Asia Pacific Association of Allergy, Asthma and Clinical Immunology
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7203436/ https://www.ncbi.nlm.nih.gov/pubmed/32411578 http://dx.doi.org/10.5415/apallergy.2020.10.e13 |